ASD and PDA closure with CeraTM and CeraFlexTM devices

Buys, D.G.; Greig, C.; Brown, Stephen C.

doi:10.24170/13-1-1686

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Incorrect device selection, as well as the inappropriate placement of the device, may play a role. There are many reports of the embolisation of various devices in the literature but the only report about the embolisation of the CeraFlex TM PDA occluder that we could find in the literature was in the study of Buys et al 26 They reported their experience with the CeraFlex TM PDA occluder in 12 patients and Cera TM occluder in 4. They used a 04/06 mm device in seven patients (58.4%), 08/10 mm in three (25%), and 06/08 mm in two (16.6%) in the CeraFlex TM occluder group.…”

Section: Discussionmentioning

confidence: 97%

Preliminary results of the Ceraflex^TM PDA occluder and device behaviour during releasing

et al. 2019

View full text Add to dashboard Cite

Introduction:The CeraFlexTM PDA occluder is a new flexible device with a unique delivery system that may be beneficial with regard to not changing the device position after releasing. We prospectively evaluate the efficacy of the device and also the device behaviour patterns during release.Methods:The study included 21 patients. Their median age was 1.2 years (from 6 months to 28 years) and weight was 9.6 kg (from 5.4 to 82 kg). All of the ducts were conical except one atypical ductus. Median ductal diameter at the pulmonary end was 3.8 mm (from 2.2 to 8.2 mm). The ductus was closed using an antegrade approach, but special attention was paid to the patterns of device behaviour during and just after releasing.Results:Three different modes of device behaviour were observed during and just after releasing: (1) Neither difficulty nor change of position in 13 patients (62%), (2) a little difficulty in releasing but no change of position in 6 (29%), and (3) change of the device position in 2 (9%). There was no residual shunt on the next day except in one patient, in whom late device embolisation occurred. The device was retrieved and another, bigger device implanted.Conclusion:The CeraFlexTM PDA occlude device seems to be safe and efficacious for patent ductus arteriosus closure. Its unique delivery system generally fixes the device in a stable position that does not change after release (91%). Minor difficulty in releasing is not uncommon; however, the major disadvantage is the need for larger sheaths for delivery.

show abstract

Section: Discussionmentioning

confidence: 97%

Preliminary results of the Ceraflex^TM PDA occluder and device behaviour during releasing

et al. 2019

View full text Add to dashboard Cite

show abstract

“…10,11 There are some techniques performed by institutes and operators individually to reduce the risk of device protrusion or to correct the protruded device, such as balloon repositioning of the device 7,8 or supporting the device by a pigtail catheter during release. 12 To our knowledge, there has been no report about balloon-assisted device releasing technique in the literature. The aim of this study is to present our experience with this technique and its benefits on reducing the risk of device protrusion and complications related to protrusion.…”

mentioning

confidence: 99%

A beneficial technique for preventing the device protrusion to the aorta during percutaneous patent ductus arteriosus closure: “Balloon-assisted device releasing technique”

et al. 2019

View full text Add to dashboard Cite

Background:Although percutaneous closure of patent ductus arteriosus is an established safe procedure, protrusion of the device to descending aorta may occur in various degrees during these procedures, especially in small infants. The aim of our study is to evaluate the benefits of balloon-assisted device releasing technique in the era of preventing device protrusion and conditions related to protrusion.Methods:One hundred and fifty-five infants, who underwent patent ductus arteriosus closure with Amplatzer duct occluder I device between January, 2012 and December, 2018, were retrospectively analysed. Balloon-assisted device releasing technique was used in 20 cases (group 1, 12.9%), between January, 2015 and December, 2018. Procedures in which the technique had been used were compared with the remaining ones (group 2, 87.1%, n = 135) with regard to device stabilisation, aortic disc protrusion to the aorta, iatrogenic coarctation, and device embolisation.Results:There was no significant difference by means of gender, age, weight, and the ductal diameter, whereas the average mean pulmonary artery pressure was significantly higher in group 1. Device protrusion and related complications were significantly higher in group 2; thus, additional catheterisations or surgical interventions were required, while no additional intervention was required in group 1.Conclusion:The balloon-assisted device releasing technique provides a good device stabilisation and prevents protrusion of the device and related complications during percutaneous patent ductus arteriosus closure in selected cases.

show abstract

ASD and PDA closure with CeraTM and CeraFlexTM devices

Abstract: We discuss our experience using the new Cera TM and Ceraflex TM (Lifetech, Nashan, Shenzhen, China) devices in closing PDAs, an ASD and PFOs. PATIENTSThis is a retrospective review of lesions closed using the Cera ABSTRACTASD AND PDA CLOSURE

Cited by 2 publications

References 3 publications

Preliminary results of the Ceraflex^TM PDA occluder and device behaviour during releasing

Preliminary results of the Ceraflex^TM PDA occluder and device behaviour during releasing

A beneficial technique for preventing the device protrusion to the aorta during percutaneous patent ductus arteriosus closure: “Balloon-assisted device releasing technique”

Contact Info

Product

Resources

About

ASD and PDA closure with CeraTM and CeraFlexTM devices

Abstract: We discuss our experience using the new Cera TM and Ceraflex TM (Lifetech, Nashan, Shenzhen, China) devices in closing PDAs, an ASD and PFOs. PATIENTSThis is a retrospective review of lesions closed using the Cera ABSTRACTASD AND PDA CLOSURE

Cited by 2 publications

References 3 publications

Preliminary results of the CeraflexTM PDA occluder and device behaviour during releasing

Preliminary results of the CeraflexTM PDA occluder and device behaviour during releasing

A beneficial technique for preventing the device protrusion to the aorta during percutaneous patent ductus arteriosus closure: “Balloon-assisted device releasing technique”

Contact Info

Product

Resources

About

Preliminary results of the Ceraflex^TM PDA occluder and device behaviour during releasing

Preliminary results of the Ceraflex^TM PDA occluder and device behaviour during releasing